[Note on the trial use of fluoromethoxyphenylpiperazine-butyrophenone (28-28 M.D.) at the time of admission].
D002090:Butyrophenones; D004565:Electroconvulsive Therapy; D001523:Mental Disorders / Q000628:therapy*; D011613:Psychotherapy; D014149:Tranquilizing Agents / Q000628:therapy*
D002090:Butyrophenones; D014149:Tranquilizing Agents
MENTAL DISORDERS/therapy; TRANQUILIZING AGENTS/therapy